Every figure on this page comes from documents Nuvation Bio Inc. Class A Common Stock filed with the exchange, and each one was checked against the document itself before publication. What could not be verified is not here.
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $32 mn | +555.6% | $-63 mn | -6.5% | -198.3% |
| Mar 2026 | $83 mn | +2598.7% | $5 mn | +110.1% | 6.5% |
| Dec 2025 | $42 mn | +633.1% | $-37 mn | +26.0% | -87.4% |
| Sep 2025 | $13 mn | +1704.7% | $-56 mn | -35.4% | -425.2% |
| Jun 2025 | $5 mn | +236.8% | $-59 mn | +87.2% | -1220.9% |
| Mar 2025 | $3 mn | — | $-53 mn | -259.9% | -1726.2% |
Watch it, and each morning it files something you get the checked numbers, the sources, and red-flag alerts when the quiet numbers move — pledges, ratings, resignations. Ask by name any evening and it is read overnight.
Start free — first week on us →Data from documents filed with the exchanges, checked against the documents themselves. This page states facts and is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI and verified against filed documents. Terms, disclosures and grievances